GE HealthCare

GEHC Health Care Market cap $34.5B as of Oct 29, 2026 16:00 ET S&P 500

Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 28, 2026

Revenue$5.51B +7% year over year

Gross profit$2.22B 40% margin

Operating profit$0.81B 15% margin

Net profit$0.62B 11% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Sep 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	5.51	100%	+7%
Radiology	2.39	44%
PDx	0.84	15%
Procedural guidance	0.72	13%
PCS	0.68	12%
Specialized ultrasound	0.67	12%
Life support solutions	0.17	3%
Other	0.05	1%
Cost of revenue	−3.29	60%
Gross profit	2.22	40% margin	+2pp
R&D	−0.32	6%	+0pp
SG&A	−1.10	20%	+0pp
Operating profit	0.81	15% margin	+2pp
Interest & other costs	−0.06
Tax	−0.13
Net profit	0.62	11% margin	+2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	5.13	100%	+7%
Imaging	2.30	45%	+7%
PDx	0.77	15%	+22%
Procedural guidance	0.72	14%	+12%
Specialized ultrasound	0.62	12%	+4%
Monitoring solutions	0.52	10%	−7%
Life support solutions	0.19	4%	−6%
Other	0.02	0%	+38%
Cost of revenue	−3.15	61%
Gross profit	1.98	39% margin	−4pp
R&D	−0.35	6%	+0pp
SG&A	−1.12	22%	+0pp
Operating profit	0.52	10% margin	−3pp
Interest & other costs	−0.03
Tax	−0.09
Net profit	0.39	8% margin	−4pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	5.70	100%	+7%
Imaging	2.26	40%
AVS	1.55	27%
PCS	0.85	15%
PDx	0.58	10%
Other	0.47	8%
Cost of revenue	−3.44	60%
Gross profit	2.26	40% margin	−3pp
R&D	−0.32	6%	−1pp
SG&A	−1.11	19%	−2pp
Operating profit	0.83	15% margin	−1pp
Tax	−0.24
Net profit	0.59	10% margin	−3pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	5.14	100%	+6%
Imaging	2.35	46%	+5%
PDx	0.75	14%	+20%
Procedural guidance	0.66	13%	+2%
Specialized ultrasound	0.64	12%	+12%
Monitoring solutions	0.54	11%	−2%
Life support solutions	0.19	4%	−16%
Other	0.02	0%	+0%
Cost of revenue	−3.15	61%
Gross profit	1.99	39% margin	−3pp
R&D	−0.29	6%	−1pp
SG&A	−1.05	20%	−1pp
Operating profit	0.65	13% margin	−1pp
Interest & other costs	−0.03
Tax	−0.18
Net profit	0.45	9% margin	−1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	5.01	100%	+3%
Imaging	2.20	44%
PDx	0.73	15%
Procedural guidance	0.66	13%
Specialized ultrasound	0.63	13%
Monitoring solutions	0.58	11%
Life support solutions	0.20	4%
Other	0.01	0%
Cost of revenue	−3.02	60%
Gross profit	1.99	40% margin	−2pp
R&D	−0.30	6%	−1pp
SG&A	−1.03	21%	−1pp
Operating profit	0.65	13% margin	+0pp
Interest & other costs	−0.06
Tax	−0.11
Net profit	0.49	10% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 28, 2026 Operating margin 15% Net profit $0.62B	Jul 1 – Sep 30, 2026	Oct 28, 2026	$5.51B	+7%	15%	$0.62B	11%
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 29, 2026 Operating margin 10% Net profit $0.39B	Jan 1 – Mar 31, 2026	Apr 29, 2026	$5.13B	+7%	10%	$0.39B	8%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 4, 2026 Operating margin 15% Net profit $0.59B	Oct 1 – Dec 31, 2025	Feb 4, 2026	$5.70B	+7%	15%	$0.59B	10%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 29, 2025 Operating margin 13% Net profit $0.45B	Jul 1 – Sep 30, 2025	Oct 29, 2025	$5.14B	+6%	13%	$0.45B	9%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Jul 30, 2025 Operating margin 13% Net profit $0.49B	Apr 1 – Jun 30, 2025	Jul 30, 2025	$5.01B	+3%	13%	$0.49B	10%